CagriSema: Activating amylin and GLP-1 receptors CagriSema from Novo Nordisk activates both GLP-1 and amylin receptors
Japans aging population and focus on managing chronic diseases like diabetes continue to support market growth
The subsidy often depends on clinical criteria established by the PBS
RAW MATERIAL CRISIS: API Prices Surge 20-106% Amid Iran Conflict INDIA - March 11-14 - The escalating West Asia conflict triggered unprecedented price increases across pharmaceutical inputs, with industry data revealing hikes of 20-106% since December 2025
(You may also see the newer terms metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) used alongside NAFLD and NASH in recent guidance.) NAFLD is strongly associated with metabolic syndrome, encompassing conditions such as obesity, type 2 diabetes, hypertension, and dyslipidaemia
(Source 1) In cases where glutathione demands are high, or there are genetics inhibit glutathione production, glutathione supplementation is often very effective